Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

Radiotherapy and Oncology

Volumn 102, Issue 2, 2012, Pages 228-233

  De Ruysscher, Dirk ^a   Van Baardwijk, Angela ^a   Steevens, Jessie ^b   Botterweck, Anita ^a   Bosmans, Geert ^a   Reymen, Bart ^a   Wanders, Rinus ^a   Borger, Jacques ^a   Dingemans, Anne Marie C ^c   Bootsma, Gerben ^d   Pitz, Cordula ^e   Lunde, Ragnar ^f   Geraedts, Wiel ^d   Oellers, Michel ^a   Dekker, Andre ^a   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

^f St Jansgasthuis ^*  (Netherlands)

Author keywords

Chemotherapy; Combined modality treatment; Individualised; Non small cell lung cancer; Radiotherapy; Stage III

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84857632570     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.10.010     Document Type: Article

References (45)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. C.S. Anderson, and W.J. Curran Combined modality therapy for stage III non-small-cell lung cancer Semin Radiat Oncol 20 2011 186 191
3. J.P. van Meerbeeck, G.W. Kramer, and P.E. Van Schil Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450
4. K.S. Albain, R.S. Swann, and V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
5. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
6. M. Machtay, K. Bae, and B. Movsas Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An Analysis of the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 82 2012 423 432
7. M. Saunders, S. Dische, and A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee Radiother Oncol 52 1999 137 148
8. M. Baumann, T. Herrmann, and R. Koch Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC) Radiother Oncol 100 2011 76 85
9. C. Le Pechoux, A. Mauguen, M. Baumann On behalf of the MAR-LC Collaborative Group Evaluation of modified fractionation radiotherapy effect in non metastatic lung cancer: an updated individual patients data meta-analysis on 10 randomized trials and 2685 patients. 14th World Conference on Lung Cancer, Amsterdam, July 2011 J Thorax Oncol 6 2011 432 433
10. D. De Ruysscher, C. Faivre-Finn, and U. Nestle European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer J Clin Oncol 28 2010 5301 5310
11. A. van Baardwijk, S. Wanders, and L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
12. A. van Baardwijk, R. Wanders, and B. Reymen First results of a phase II trial investigating individualized dose-escalation based on normal tissue constraints in concurrent chemo-radiation for locally advanced non-small cell lung cancer (NSCLC) (NCT00572325) Int J Radiat Oncol Biol Phys 78 2010 S108
13. World Health Organization. International Classification of Diseases for Oncology (ICD-O-3), 3rd ed. Geneva; 2000.
14. L.H. Sobin, and Ch. Wittekind International Union Against Cancer (UICC). TNM Classification of Malignant Tumours 6th ed. 2002 Wiley-Liss New York
15. L.J. Schouten, P. Hoppener, and P.A. van den Brandt Completeness of cancer registration in Limburg, The Netherlands Int J Epidemiol 22 1993 369 376
16. M. Charlson, T.P. Szatrowski, and J. Peterson Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245 1251
17. P. Therasse, S. Arbuck, and E. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
18. ICRU Report 50. Prescribing, Recording, and reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements. 1993.
19. D. De Ruysscher, S. Wanders, and E. van Haren Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 62 2005 988 994
20. C. Pöttgen, W.E. Eberhardt, and T. Gauler Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial Int J Radiat Oncol Biol Phys 76 2010 809 815
21. J.T. Annema, J.P. van Meerbeeck, and R.C. Rintoul Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial JAMA 304 2010 2245 2252
22. J.S. Belderbos, W.D. Heemsbergen, and K. De Jaeger Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134
23. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333
24. D. De Ruysscher, R. Wanders, and E. van Haren HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 71 2008 132 138
25. M. Partridge, M. Ramos, and A. Sardaro Dose escalation for non-small cell lung cancer: analysis and modelling of published literature Radiother Oncol 99 2011 6 11
26. A. van Baardwijk, G. Bosmans, and S.M. Bentzen Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial Int J Radiat Oncol Biol Phys 71 2008 1103 1110
27. N. Lorent, P. De Leyn, and Y. Lievens Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience Ann Oncol 15 2004 1645 1653
28. P. Garrido, J.L. González-Larriba, and A. Insa Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901 J Clin Oncol 25 2007 4736 4742
29. C. Dehing-Oberije, H. Aerts, and S. Yu Development and Validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325) Int J Radiat Oncol Biol Phys 81 2011 360 368
30. C.Q. Zhu, K. Ding, and D. Strumpf Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer J Clin Oncol 28 2010 4417 4424
31. Y.T. Huang, R.S. Heist, and L.R. Chirieac Genome-wide analysis of survival in early-stage non-small-cell lung cancer J Clin Oncol 27 2009 2660 2667
32. P. Lambin, S.F. Petit, and H.J. Aerts The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiother Oncol 96 2010 145 152
33. S. Gaede, J. Olsthoorn, and A.V. Louie An evaluation of an automated 4D-CT contour propagation tool to define an internal gross tumour volume for lung cancer radiotherapy Radiother Oncol 101 2011 322 328
34. C. Siedschlag, L. Boersma, and J. van Loon The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer Radiother Oncol 100 2011 344 350
35. J. St-Hilaire, C. Lavoie, and A. Dagnault Functional avoidance of lung in plan optimization with an aperture-based inverse planning system Radiother Oncol 100 2011 390 395
36. M.R. McCurdy, M.W. Wazni, and J. Martinez Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation Radiother Oncol 101 2011 443 448
37. J.L. Lopez Guerra, Q. Wei, and X. Yuan Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy Radiother Oncol 101 2011 271 277
38. A. Bertelsen, T. Schytte, and S.M. Bentzen Radiation dose response of normal lung assessed by Cone Beam CT - a potential tool for biologically adaptive radiation therapy Radiother Oncol 100 2011 351 355
39. C. Dehing-Oberije, D. De Ruysscher, and S. Petit Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients Radiother Oncol 97 2010 455 461
40. D. De Ruysscher, A. Houben, and H.J. Aerts Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study Radiother Oncol 91 2009 415 420
41. K. De Ruyck, N. Sabbe, and C. Oberije Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy Int J Radiat Oncol Biol Phys 81 2011 537 544
42. C. Dehing-Oberije, D. De Ruysscher, and A. van Baardwijk The importance of patient characteristics for the prediction of radiation-induced lung toxicity Radiother Oncol 91 2009 421 426
43. H.J. Aerts, P. Lambin, and D.D. Ruysscher FDG for dose painting: a rational choice Radiother Oncol 97 2010 163 164
44. M. Pijls-Johannesma, R. Houben, and L. Boersma High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL Radiother Oncol 91 2009 443 448
45. D. De Ruysscher, C. Dehing, and S. Yu Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer Radiother Oncol 91 2009 353 359